Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis

Summary

The study aims to evaluate the efficacy, improvement from baseline in Eczema Area and Severity Index (EASI) score, of multiple intravenous (IV) doses of FB825 in subjects with atopic dermatitis

Timeline

Start

2020-03-10

Primary completion

2021-12-31

Completion

2022-06-30

Drugs

Indications